Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal CO2 for Ischemia Reperfusion Injury in Placenta Accreta
NCT05205304Phase 4Unknown
- Sponsor
- Universitas Airlangga
- Start
- Mar 2022
- Primary completion
- Dec 2022
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in placenta accreta (PAS) (2 arms), sponsored by Universitas Airlangga. Primary endpoint: Malondialdehyde. Status: unknown.
02
Conditions
placenta accreta (PAS)
Beyond the preview
Go deeper on NCT05205304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05205304.